Anal Cancer: Across the Spectrum of Care
Anal cancer rates are increasing, and there is a need to improve coordination across the spectrum of anal cancer care, from diagnosis, treatment, recovery and survivorship. Failure to understand the roles of all the multidisciplinary aspects of care leads to suboptimal patient care.  
Category
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Brachytherapy for Cervical Cancer from A to Z: Optimizing Patient Selection, Treatment Delivery, and Patient Experience
Brachytherapy is a critical component to the optimal management of locally advanced cervical cancer. However, due to many factors, its use was declining in the 2010s and when brachytherapy is omitted, patient outcomes are worse.
Category
  • Brachytherapy
  • Gynecologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Multidisciplinary Patient-Based Approach to Challenging Situations with Cervix Cancer
Cervical cancer continues to be a common cancer globally, especially in less developed regions and some underserved areas in the US where advanced stage presentations are common. Recently published clinical trials looked at addition of novel agents to standard chemoradiation.
Category
  • Gynecologic
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Oligometastatic Breast Cancer: Considering Patients One by One
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
  • Breast
  • Oligometastatic
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Challenging Cases in Breast Cancer: Rare Breast Cancer Histologies and Presentations
This activity includes a panel of experts from breast radiation oncology, surgical oncology, medical oncology, and pathology to discuss the following rare histologies/breast cancer presentations: 1) Pleomorphic LCIS- diagnosis and differential (path) appropriate margin width (surgeon), role of ad
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Considerations for Treatment of PSMA-Staged High-Risk Patients in Community Practice
This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Salivary and Sinonasal Tumors: Multi-Disciplinary Individualization of Patient Care
Sinonasal and salivary malignancies are less common head and neck tumors but are still frequently seen by radiation oncologists and pose complex clinical decision making challenges due to the proximity to the facial nerve, optic structures, brain, and oral cavity.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Which Patients Benefit from Radiation Therapy in Diffuse Large B-Cell Lymphoma in 2023? Recent Evidence and Future Developments
The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Session - When Every Centigray Counts: Expert Panelists on Approaching and Optimizing the Most Challenging Lymphoma Plans
Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages